TheraVet SA
ISIN: BE0974387194 | Ticker: ALVET | LEI: 984500804EBR3F1EFF71
Country: Belgium
TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.
TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases.
TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.
TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.
2017
Served areaWorldwide
HeadquartersAvenue Jean Mermoz 32/1, 6041 Charleroi, Hainaut – Belgium
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 21.11.23 | Bastianelli Enrico | Board | Other | EUR 380,000.00 |
BE0974387194
LEI984500804EBR3F1EFF71
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.